Imaging, Digital, Angiography Symposium 1

Related

• 

  Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

  Hani Salehi-Had, MD, FASRS

  Annual Meeting Talks

  2023

• 

  What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study

  Roger A. Goldberg, MD, MBA

  Updates from the Field

  2019

• 

  Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

  Charles C Wykoff, MD, PhD, FASRS

  Updates from the Field

  2017